(Total Views: 712)
Posted On: 12/30/2021 4:49:55 PM
Post# of 72436
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Found this post on another site. Am currently trying to confirm it is legit. If so, very telling in that something seems wacky (or a more criminal term) in therapeutic trials to date for Covid.
Edit:: FOUND THE ARTICLE
https://www.ama-assn.org/delivering-care/publ...ence-shows -- Does anyone really believe the FDA could possibly be this wrong so consistently? Sure brings me to a belief of sinister intentions.
I decided to do a little more DD on underpowered trials. I found that on 17 March 2021, the AMA hosted the 6th webinar titled "CV 19 what physicians need to know". The subject was, FDA experts discuss CV 19 therapeutic clinical trials.
Reading through I found that out of 2900 therapeutic trials in the US and around the world, Only 5 % were sufficiently powered, and the speaker reiterated Only 5 % were designed appropriately.
Folks can draw their own conclusions regarding Ipix and the trial designers now knowing this info that I've provided.
Edit:: FOUND THE ARTICLE
https://www.ama-assn.org/delivering-care/publ...ence-shows -- Does anyone really believe the FDA could possibly be this wrong so consistently? Sure brings me to a belief of sinister intentions.
I decided to do a little more DD on underpowered trials. I found that on 17 March 2021, the AMA hosted the 6th webinar titled "CV 19 what physicians need to know". The subject was, FDA experts discuss CV 19 therapeutic clinical trials.
Reading through I found that out of 2900 therapeutic trials in the US and around the world, Only 5 % were sufficiently powered, and the speaker reiterated Only 5 % were designed appropriately.
Folks can draw their own conclusions regarding Ipix and the trial designers now knowing this info that I've provided.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)